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Abstract: This is the first cost-effectiveness analysis of Chuna manual therapy (CMT) plus usual
Korean traditional medicine for traffic accident victims using a randomized controlled trial. A total of
132 participants were equally allocated to the intervention group receiving 6–11 sessions of CMT plus
usual Korean traditional medicine care for three weeks or usual care including acupuncture, cupping,
herbal medicine, moxibustion, and traditional physiotherapy at three hospitals. At 12 weeks, from
a healthcare perspective, the intervention group had significantly higher costs (mean (SD), $778
(435) vs. $618 (318); difference, $160; 95% CI, $15 to $289; p = 0.005). From a societal perspective,
total costs were insignificantly lower in the intervention group (mean (SD), $1077 (1081) vs. $1146
(1485); difference, $−69; 95% CI, $−568 to $377; p = 0.761). The intervention group dominated, with
significantly higher QALYs gained at lower overall cost with a 72% chance of being cost-effective.
From a societal perspective, the intervention was cost-saving for individuals who had neck pain after
car accidents, although it was not cost-effective from the healthcare perspective ($40,038 per QALY
gained). Findings support use of CMT as an integrated care treatment for whiplash from a societal
perspective. Further studies with larger sample sizes are needed to determine cost-effectiveness in
other cultural contexts.
Keywords: cost-effectiveness; complementary and integrated medicine; Chuna manual therapy;
neck pain; traffic accidents
1. Introduction
There can be substantial costs to individuals and families for healthcare, productivity
losses, and informal care for Whiplash Associated Disorders (WAD). The annual costs of
WAD in Europe are EUR 10 billion [1]. Insurance claim costs are considerable, as 60% of
patients with acute WAD can develop chronicity [2], with lingering pain and deteriorating
quality of life and employability [3]. One year after injury, 50% of people with WAD still
experience neck pain due to subtle soft tissue damage that is not easily detected [4,5].
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In 1999 in South Korea, the automobile compensation insurance scheme was expanded
to include Korean traditional medicine, leading to an increase in use of complementary
alternative medicine [6,7]. Approximately 30% of people with neck pain use manual
therapies to manage their conditions [8] Patients without fractures and nerve damage tend
to prefer Korean traditional medicine, as it is a less invasive, non-pharmacological approach.
They are reluctant to use painkillers and painful injections [9,10]. A systematic review
and meta-analysis of randomized clinical trials (RCTs) for Chuna (Tuina) manual therapy
(CMT) showed significant reductions in musculoskeletal pain [11] and nonspecific chronic
neck pain [12]. A recent RCT of CMT plus standard care for whiplash took significantly
fewer days to reach a 50% reduction in pain, compared with standard care (23 vs. 50 days,
p = 0.01) [13].
Despite increasingly positive clinical effectiveness studies, there are few economic
evaluations of manual therapies for WAD/neck pain following car accidents worldwide.
With increasing car insurance claims for WAD, it is important to look at cost-effectiveness
of CMT as an adjunct therapy to usual care for WAD in a South Korean context to facilitate
more optimal resource allocation decisions. This is the first cost-effectiveness analysis for
CMT alongside a RCT in this population.
2. Materials and Methods
2.1. Trial Design and Participants
Patients aged 19–70 with whiplash lasting between two and 13 weeks following a
traffic accident were recruited. Patients who consented, and did not have fractures or
neurological damage, were allocated using block randomization (block size = 4) to CMT
plus usual care or usual care only between August 2019 and February 2020 with 12-week
follow-up ending in August 2020 (Figure S1). Neck pain was measured using a numeric rat-
ing scale (NRS) score ≥ 5 (moderate) and diagnosed with Whiplash Associated Disorders
(WAD) grade I, II [14]. The study was approved by the ethics committees of the participat-
ing hospitals (Busan National University Korean Medicine Hospital-2019004, Kyung-Hee
University Korean Medicine Hospital-KHNMCOH 2019-05-001-001, and Jaseng Hospi-
tal of Korean Medicine in Seoul-JASENG 2019-04-014-002). To estimate sample size, a
previous clinical study that treated a pharmacopuncture (herbal acupuncture) treatment
group, CMT only group, and combination pharmacopuncture and CMT treatment group
two times per week for 4 weeks was used as a reference [15]. The minimum number
of participants required for hypothesis testing was calculated using G*Power 3.1.9.2 for
Windows (Heinrich-Heine-Universität, Düsseldorf, Germany) as 46 participants per group.
Considering a 30% dropout rate, we enrolled 132 participants for the powered sample size.
2.2. Interventions
CMT can be defined as a Korean traditional medicine modality based on Tuina in
Traditional Chinese Medicine along the meridians “integrating with modern scientific
knowledge on anatomy, physiology, pathology from American chiropractic practice, os-
teopathy, and Japanese manipulation techniques, by correcting osteopathic structures using
thrust, mobilization, distraction of the spine and joints, visceral manipulation and soft
tissue release” [16]. Intervention consisted of 6 to 11 sessions of CMT plus usual care (UC).
UC included acupuncture, cupping, moxibustion, herbal medicines, and physiotherapy.
CMT was performed by Korean Medicine doctors with more than 3 years’ experience. The
first session lasted 20 min, with subsequent treatments lasting 15 min.
2.3. Effectiveness
Impacts on quality of life were measured at baseline, 3, 6, and 12 weeks after inter-
vention. Self-reported quality of life scores were measured using the EQ-5D-5L question-
naire [17,18]. Quality Adjusted Life years gained (QALYs) were calculated using the area
under the curve method [19] at 12-week follow up.
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2.4. Cost-Effectiveness Analysis
Cost-effectiveness analysis was conducted alongside the RCT and reported here as
recommended in the Consolidated Health Economic Evaluation Reporting Standards
(CHEERS) guidelines [20]. The evaluation was performed from both healthcare payer
and societal perspectives. In South Korea, this evaluation will be of interest to healthcare
providers such as hospitals, as well as car insurance providers, the major funders of health-
care services arising from traffic accidents. Data on prescribed medications, emergency
visits, inpatient days in conventional western and traditional Korean Medicine hospitals,
day care, outpatient care, and diagnostic tests such as X-rays were collected by patient
self-report, using an adapted version of the Client Service Receipt Inventory (CSRI) [21]
at baseline, 3, 6, and 12 weeks. This instrument is widely used to collect health services-
related resource use through self-report. Intervention costs were estimated by examining
electronic patient records.
Societal costs included out-of-pocket payments for over-the-counter food supplements
(multivitamins, omega-3 fish oil, calcium, painkillers, collagen, and glucosamine). Travel-
time costs for patients’ carers for Korean Medicine hospital visits were calculated using the
official minimum wage rate of $10 per hour [22]. Transportation expenses were estimated
for use of private and public transport. Absenteeism and informal care costs were estimated
using a human capital approach, assuming each day absent from work or providing
informal care was equivalent to 8 h on minimum wage.
Relevant unit costs from the national automobile insurance providers association were
applied to all health resources used (Tables S3–S5) [23]. All costs were converted from
South Korean Won (2019) to 2020 purchasing power parity (PPP) international dollars ($),
using the IMF currency conversion and inflation rates [24].
2.5. Statistical Analysis
Economic analyses were performed using the intention-to-treat principle. Cost com-
parisons were made at four timepoints over 12 weeks. Baseline costs included costs for
health services and societal costs. Independent t-tests were performed and 95% confidence
intervals estimated using bias-corrected accelerated bootstrapping, given skewed cost
distributions.
Incremental cost per QALY gained, using the net-benefit approach [25], was estimated.
Discounting was not performed as the intervention lasted less than one year. In sensitiv-
ity analyses, alternative scenarios explored whether results remained robust by varying
intervention costs and effects, and including imputed values.
In cost-effectiveness planes, joint distributions of incremental mean costs and QALYs
for CMT+UC versus UC groups were generated using non-parametric bootstrapping with
1000 replications to explore the probability of intervention being a better option at the
willingness-to-pay (WTP) level set by funders for improved quality of life in South Korea.
Cost-effectiveness acceptability curves were generated by plotting these probabilities at
various WTP values. Missing costs and outcomes were imputed using multiple imputation
with predictive mean matching to deal with skewness [26,27]. All analyses were 2-tailed,
and a p-value of < 0.05 was considered significant. Data were analyzed using SPSS 24 [28]
and STATA 15 [29].
3. Results
3.1. Effectiveness
A total of 132 participants (mean (SD) age, 40.0 (11.8) years; 91 (69%) women and 41
(31%) men) were allocated evenly to CMT+UC or UC groups. There were no significant
differences in age, gender, height, weight, and BMI at baseline. (See baseline characteristics
in Table S1). At a 12-week follow-up the CMT+UC group showed significantly better
quality of life than the UC group (mean (SD) QALY gained per person, 0.193 (0.010) vs.
0.189 (0.010); mean difference, 0.004; 95% CI, 0.0002 to 0.007; p = 0.037) (see Table S2).
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3.2. Intervention Costs
The CMT+UC group had significantly higher intervention costs, compared with the
UC only group (mean (SD), $639 (214) vs. $462 (136); difference, $177; 95% CI, $112 to
$236; p = 0.001). No significant difference was found for UC costs between the two groups
(mean (SD), $457 (160) vs. $458 (130); difference, $−1; 95% CI, $−49 to $58; p = 0.097). This
indicates randomization between the two groups was successful, implying the incremental
cost difference can be attributed to additional Chuna costs.
3.3. Health Service Costs
In Table 1, baseline costs were used to check whether there were statistically significant
differences in costs before receipt of treatment; no differences were found. Thus, any cost
differences incurred after intervention can be attributed to the difference made as a result of
intervention in the RCT. Baseline inpatient costs at Korean Medicine hospitals for CMT+UC
group were non-significantly higher than the UC group by $25 (mean (SD), $463 (970) vs.
$438 (815); mean difference, $24; 95% CI, −285 to 338; p = 0.88).
Table 1. Health care costs at four timepoints.
Chuna+Usual Care Usual Care Difference BCa 95% ConfidenceInterval
Cost Category Time N Mean SD N Mean SD Mean Lower Upper p-Value
Drug cost Baseline 66 5 11 65 7 13 −2 −6 2 0.31
3 weeks 61 0 2 61 0 1 0 0 1 0.999
6 weeks 61 1 2 60 0 1 0 0 1 0.41
12 weeks 58 1 4 62 1 3 0 −1 2 0.53
Emergency Baseline 66 43 61 65 52 72 −9 −30 13 0.46
3 weeks 61 2 17 61 2 17 0 −6 6 0.999
6 weeks 61 0 0 60 0 0 0 . . .
12 weeks 58 0 0 62 2 16 −2 −8 2 0.12
Inpatient care at
conventional hospitals
Baseline 66 176 503 66 298 608 −122 −312 85 0.21
3 weeks 61 0 0 61 0 0 0 . . .
6 weeks 61 0 0 60 0 0 0 . . .
12 weeks 58 0 0 62 0 0 0 . . .
Inpatient care at Korean
Medicine hospitals
Baseline 66 463 970 66 438 815 24 −285 338 0.88
3 weeks 61 0 0 61 0 0 0 . . .
6 weeks 61 0 0 60 0 0 0 . . .
12 weeks 58 0 0 62 0 0 0 . . .
Outpatient Baseline 66 317 385 66 335 438 −18 −149 127 0.80
3 weeks 61 47 121 61 48 120 −1 −46 39 0.96
6 weeks 61 46 105 60 40 93 6 −30 43 0.75
12 weeks 58 53 245 62 72 183 −19 −89 72 0.64
Diagnostic tests Baseline 66 15 21 66 17 22 −3 −11 5 0.46
3 weeks 61 1 3 61 1 4 0 −2 1 0.76
6 weeks 61 1 5 60 0 2 1 0 2 0.32
12 weeks 58 1 5 62 1 7 0 −3 2 0.75
Abbreviations: SD, standard deviation; Bca: biased-corrected accelerated bootstrap.
Emergency care costs were lower in the CMT+UC group. No inpatient care costs in
conventional western or traditional Korean medicine hospitals were incurred during follow-
up. This may be as patients had relatively minor to moderate neck injuries (Whiplash
Associated Disorder grade 1 or 2). There were no daycare costs. Costs for outpatient care
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and diagnostic tests were less costly at 3-weeks and 12-weeks in the CMT+UC versus UC
group, while slightly higher at 6 weeks.
Overall, healthcare costs, excluding intervention costs, were lower for the CMT+UC
group (Mean (SD), $148 (340) vs. $164 (292); mean difference, $−16; 95% CI, −115 to 84;
p = 0.785). When including intervention costs, healthcare costs were significantly higher
by $160 (Mean (SD), $778 (435) vs. $618 (318); mean difference, $160; 95% CI, 15 to 289;
p = 0.005).
3.4. Societal Costs
Societal costs at four different timepoints are reported in Table 2. From this perspective,
there were no significant differences in costs at baseline. Productivity losses due to sickness
absence by patients were consistently higher in the UC group from baseline until 12-weeks,
although this was not significant. No informal care costs were incurred, as patients had
relatively minor neck injuries, but this could be due to cultural perception, as patients
may not have considered help received, such as support with daily activities of living (e.g.,
cooking, shopping, and cleaning) from family or friends as “extra” support.
Table 2. Societal costs at four time-points.




Cost Category Time N Mean SD N Mean SD Mean Lower Upper p-Value
Food supplements Baseline 66 5 20 66 9 32 −4 −14 5 0.44
3 weeks 61 3 11 61 5 21 −2 −9 3 0.47
6 weeks 61 1 6 60 5 27 −4 −12 1 0.36
12 weeks 58 5 20 60 2 8 3 −1 9 0.27
Travelling costs Baseline 54 19 8 44 21 7 −2 −5 1 0.14
3 weeks 61 32 16 61 34 22 −2 −9 5 0.56
6 weeks 61 12 29 60 8 25 4 −6 14 0.41
12 weeks 58 12 49 60 13 32 −1 −16 17 0.87
Transportation costs
Baseline 66 72 348 66 43 81 29 −27 130 0.57
3 weeks 61 4 13 61 8 35 −4 −16 5 0.46
6 weeks 61 6 23 60 5 14 1 −5 8 0.88
12 weeks 58 3 10 60 13 36 −10 −20 −2 0.07
Absenteeism costs Baseline 45 425 612 42 710 852 −285 −608 18 0.09
3 weeks 61 31 172 61 94 342 −63 −169 31 0.22
6 weeks 61 43 253 60 82 296 −38 −141 67 0.45
12 weeks 58 30 227 60 142 633 −112 −313 54 0.26
SD: standard deviation, BCa: bias-corrected and accelerated bootstrap.
Overall, societal costs over 12 weeks, excluding intervention costs, were non-
significantly lower in the CMT+UC group (Mean (SD), $466 (994) vs. $716 (1486); mean
difference, $−250; 95% CI, −715 to 178; p = 0.317). Similarly, after including intervention
costs, accumulated societal costs were still non-significantly lower by $69 (Mean (SD), 1077
(1081) vs. 1146 (1485); mean difference, $−69; 95% CI, −568 to 377; p = 0.761).
3.5. Incremental Cost-Effectiveness Ratio
From the healthcare perspective, the ICER, calculated as incremental costs divided
by incremental effects is $40,038 per QALY. This is higher than the accepted WTP level of
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20,000,000 Won ($24,656) per QALY in South Korea. From a societal perspective, with no
significant difference in costs and better outcomes, the CMT+UC group is considered the
dominant option and, by convention, the ICER is not reported.
3.6. Sensitivity Analyses
Sensitivity analyses were performed to explore impacts of varying assumptions. We
examined using a minimum of just one Chuna session over the 3-week intervention period,
instead of at least 2 sessions per week over 3-weeks. Interestingly, although costs in the
CMT+UC group were $11 higher than the UC group (Mean (SD), 168 (332) vs. 157 (287);
mean difference, $11; 95% CI, −94 to 124; p = 0.86), the cost difference was no longer
significant from the healthcare perspective. From a societal perspective, costs decreased by
$217 (Mean (SD), 467 (970) vs. 684 (1459); mean difference, $−217; 95% CI, −707 to 219;
p = 0.32).
Using imputed costs did not change the final conclusions, given the small percentage
(8–9%) of missing data in both arms. Imputed total healthcare costs were significantly more
expensive in the CMT+UC versus UC group, due to the extra cost of CMT (Mean (SD),
796 (416) vs. 633 (307); mean difference, $163; 95% CI, 30 to 288; p = 0.01). Imputed total
societal costs were less in the CMT+UC versus UC group (Mean (SD), 1137 (1051) vs. 1193
(1456); mean difference, $−56; 95% CI, −550 to 411; p = 0.80). Sensitivity analyses showed
no major impact on interpretation of findings.
3.7. Cost-Effectiveness Planes
Figure 1 shows the cost-effectiveness plane from the healthcare payer perspective.
Most simulated paired dots, after bootstrapping 1000 times, were scattered above the
accepted threshold line of 20,000,000 won ($24,656) (green line) in the north-east quadrant.
This means CMT+UC was more costly than UC, but more effective. In this case, cost-
effectiveness can be determined using the threshold value. The ICER (red dot) is above the
threshold, indicating that CMT+UC was not cost-effective from the healthcare perspective.




Figure 1. Cost–Effectiveness Plane (healthcare payer perspective). Red dot: Incremental cost-effectiveness ratio, Green 
line: willingness-to-pay threshold. 
In contrast, from the societal perspective, the majority of paired dots after bootstrap-
ping 1000 times, were scattered below the threshold value. The ICER (red dot) was also 
located in the south-east quadrant in Figure 2. This indicated CMT+UC was less costly 
and more effective (i.e., better quality of life) in the simulated cost-effectiveness plane, 
compared with usual care only. 
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In contrast, from the societal perspective, the majority of paired dots after bootstrap-
ping 1000 times, were scattered below the threshold value. The ICER (red dot) was also
located in the south-east quadrant in Figure 2. This indicated CMT+UC was less costly
and more effective (i.e., better quality of life) in the simulated cost-effectiveness plane,
compared with usual care only.
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In contrast, from the societal perspective, the majority of paired dots after bootstrap-
ping 1000 times, were scattered below the threshold value. The ICER (red dot) was also 
located in the south-east quadrant in Figure 2. This indicated CMT+UC was less costly 
and more effective (i.e., better quality of life) in the simulated cost-effectiveness plane, 
compared with usual care only. 
 
Figure 2. Cost–Effectiveness Plane (societal perspective). Red dot: Incremental cost-effectiveness ratio, Green line:
willingness-to-pay threshold.
3.8. Cost-Effectiveness Acceptability Curves
In Figure 3, the cost-effectiveness acceptability curve from the health payer perspec-
tive, indicates only a 24% chance of CMT+UC being cost-effective at the threshold value.
However, in Figure 4 from the societal perspective there was a 72% chance of CMT+UC
being cost-effective, with costs in the CMT+UC group likely to be lower than costs in the
UC group.
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4. Discussion
From a societal perspective, the probability that CMT+UC was cost saving at 12-weeks
was very high, even at very low levels of willingness to pay. Most cost savings were driven
by reductions in productivity loss from sickness absence and travel-time transportation
costs in the CMT+UC group. Depending on the perspective of the economic analysis, the
results differ, as it was unlikely to be cost-effective from a healthcare payer perspective.
Therefore, it is important to consider a broad societal perspective that captures more of
the full costs and benefits to society, otherwise we might dismiss promising interventions.
After all, payers to car insurance companies and taxpayers to the healthcare system are
individual service users.
The lack of significant difference in most health service and societal costs could be
attributed to the lack of power to detect significant differences at four time points due to
the small sample size. It is also worth noting that greater sample sizes are generally needed
to detect a significant difference in costs compared to effects, although in practice, power
calculations for RCTs are usually based on primary clinical outcomes rather than costs [19].
Therefore, further RCTs with larger sample sizes might be helpful to confirm differences in
costs are significant.
4.1. Generalizability of Findings
This study was conducted in South Korea, a country where CMT is commonly pro-
vided within the integrated healthcare system and used by the general population seek-
ing help for pain management. Chuna has been included within the traditional Korean
Medicine standard care package reimbursed by automobile insurance providers since 1999.
South Korea has a well-integrated health system combining CAM modalities and
western medicine. Various traditional Korean medicine modalities for pain management
are provided as a part of the standard care package for victims of road traffic accidents
including whiplash injuries. Moreover, health care costs after car accidents are covered
entirely by car insurance companies, and insurance is mandatory for every driver under
the Korean Automobile Act [30]. Private car insurance companies and medical institutions
directly pay these treatment costs, and patients are not usually directly involved in the
transaction process. Although no direct payments for treatment by patients may appear to
be a moral hazard, encouraging patients to overconsume services, there is a cap on care set
by car insurance companies. Patients can choose their preferred services within this cap,
depending on clinical needs, in consultation with medical professionals. In addition, South
Korea has a high number of Korean Medicine practitioners in private practice compared
with CAM practitioners in other western countries. Although provision of CMT to patients
with neck pain after automobile accidents may not be directly comparable, additional
provision of manual therapy as part of multimodal care can be comparable to practice in
other western countries [31].
In previous studies, cost-effectiveness was more favorable to manual therapies when
economic evaluations were conducted from societal rather than healthcare payer perspec-
tives. In the UK, from the National Health Service (NHS) payer perspective, physiotherapist
manual therapy, in addition to advice and exercise, was not cost-effective, compared with
advice and personalized exercise, being more costly ($239 vs. $211) and less effective (0.342
vs. 0.362) [32]. However, from a societal perspective, manual therapy became cost-effective
at $19,279 per QALY, an acceptable threshold value.
Similarly, in another UK NHS study, usual physiotherapy, including manual therapy,
acupuncture, electrotherapy, and advice, relative to brief intervention by physiotherapists
via self-care and cognitive behavioral therapies was not cost-effective at $142,892 per
QALY gained [33] Other studies conducted from a societal perspective showed more
favorable results. Manual therapy including manipulation, mobilization, advice, and
exercise was dominant, compared to behavioral graded activity, aiming to increase the
activity levels over time by physiotherapists [34]. In a Dutch study, manual therapy for
muscular mobilization and stabilization was found to be a dominant strategy, compared
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with usual physiotherapy including massage, relaxation techniques, and traction. Manual
therapy was also dominant, relative to usual care by general practitioners including advice
on good posture, educational leaflets on self-care and anti-inflammatory medications [35].
Therefore, our cost-effectiveness study results are consistent with general trends in
existing studies, in that the broader the economic perspective, the more cost-effective
manual therapy is when provided in combination with various therapies and/or usual
care. Reduced costs associated with productivity losses and better quality of life from
manual therapy can potentially generate cost-savings to society as a whole. More studies
are needed to confirm generalizability internationally in different socio-cultural contexts.
4.2. Strengths
To our best knowledge, our present study is the first cost-effectiveness analyses
alongside an RCT for CMT in patients with whiplash after traffic accidents, although
we have highlighted economic evaluations for non-invasive manual therapies for neck
pain associated disorders. Given the lack of economic evidence on manual therapies for
people experiencing neck pain after car accidents worldwide, our study will contribute
to bridging the gap in research in this field. Economic evidence can facilitate relevant
stakeholders, such as funders and healthcare professionals, to make optimal decisions
on scarce resource allocation, as CMT is non-invasive and improves quality of life. From
the healthcare payer/car insurance perspective, it was more expensive than UC, but is a
dominant strategy, potentially cost-saving at a societal level. Results remained robust in
sensitivity analyses.
4.3. Limitations
We did not have access to electronic records on the wider use of health services by
patients or on their productivity losses and instead relied on patient recall. However, to
minimize any risk of bias, we adapted a validated and widely used approach to collecting
self-report data, the CSRI [21]. In health economic evaluations, it is very well established
and well accepted to ask patients for the service use for the past 3 months or less than
3 months, without recall bias being a substantial concern [36]. In our study, as the time
periods (3 weeks, 6 weeks) were much shorter than the typically accepted 3 month recall
period, we do not believe recall bias is a significant concern.
In our analysis there did not appear to be any informal care costs associated with injury,
however this might be an underestimation of the costs associated with the actual informal
care provided by carers, as respondents might have considered caring as a culturally moral
duty rather than as an “extra” caring activity. We might have addressed this issue by
providing some illustrative examples of what we meant by informal care, such as helping
with daily activities of living (e.g., preparing extra meals, grocery shopping, monitoring
medication times, paying bills, etc.). This might have helped respondents to have better
understanding of caring activities in the resource use questionnaire.
We also conservatively did not ask about productivity losses that were not related to
work. However, not everyone who is injured in a car-accident will be in paid employment,
but they can still incur opportunity costs related to unpaid productive activities. For
example, their own caring responsibilities (e.g., looking after children or parents) may be
affected. There are also potential opportunity costs associated with lost unpaid productive
activities, such as volunteering in the local community. These might be considered in future
studies.
Considering implementation in other countries, the intervention may not be feasible
due to differences in treatment costs covered by healthcare systems and availability of
trained therapists. Potentially, it could be considered for medical training curriculums
and/or training programs for physiotherapists, depending on whether there is demand
from patients as an add-on therapy in outpatient settings as part of care pathways, given
improved productivity and quality of life outcomes. Future economic studies can also
explore the economic consequences of using well-being measures, given the non-invasive
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therapeutic nature of CMT. The potential for cost-saving would be even greater when
tested in RCTs with larger sample sizes and longer follow-up periods.
5. Conclusions
From a societal perspective, adding CMT to usual care is potentially cost-saving, while
significantly improving quality of life in patients with whiplash following car accidents.
The results suggest Chuna can be an optional add-on therapy. More economic studies
with larger sample sizes might be useful to help determine cost-effectiveness of CMT
internationally, taking into account the extent to which integrated care modalities are
incorporated into usual care in various health systems and cultural settings.
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